Search

Targeting Prostate Cancer in the Metastatic Setting

Mayer Fishman, MD, PhD

Castration Resistant Prostate Cancer (CRPC), Non-Metastatic & Metastatic:...

Michael Hurwitz, MD, PhD

Updates in Prostate Cancer

Ulka Vaishampayan, MD

Castration Resistant Prostate Cancer: What is the optimal...

David I. Quinn, MBBS, PhD, FRACP, FACP

State of the Art: Hormone-sensitive Prostate Cancer

Tanya Dorff, MD

Prostate and Bladder Cancer Updates

Guru P. Sonpavde, MD

Targeted Therapy in Prostate

Ulka Vaishampayan, MD

Prostate and Bladder Cancer

Daniel Petrylak, MD

Prostate Cancer (no IO): Hormonal, PARP Inhibitors and...

Ulka Vaishampayan, MD

HRPC: How to Sequence Multiple Therapies

Daniel P. Petrylak, MD

Castration Resistant Prostate Cancer: What is the optimal...

Sarmad Sadeghi (USC)

Targeted Therapy in Prostate

Alan J. Koletsky, MD

Hormone Sensitive Metastatic Prostate Cancer intensification is a...

Tanya B. Dorff, MD

Prostate Cancer Management

Mayer Fishman, MD, PhD

Surfing Between Therapeutic Options for HRPC

Daniel Petrylak, MD

State of the Art Sequencing of Treatment in...

Michael E. Hurwitz, MD, PhD